Current issue Diabetes and obesity

3

8

Experience with the management of patients with extreme obesity – Part 2

Adela Penesová

16

Tirzepatide – a dual incretin agonist in the management of type 2 diabetes mellitus: a review of evidence from the SURPASS trials

Ingrid Dravecká

23

Efficacy and safety of canagliflozin – a brief overview of the results of relevant clinical studies (meta-analyses and network analyses)

Zbynek Schroner

26

Physical activity with a hybrid closed-loop system

Eva Horová, Eliška Zadáková

31

The addictive potential and the neurobiological mechanisms underlying the consumption of hyperpalatable foods: Does food addiction exist?

Eva Klanduchová

37

Mild autonomous cortisol secretion from a diabetologist's point of view

Jozef Lacka, Barbora Lacková

42

How should we proceed today with primary prevention of cardiovascular disease – data affects women

Ján Murín

47

Patients with T2DM without present CVD but with already present risk CV-factors: case reports

Valéria Mokrá, Monika Masarovičová, Zbynek Schroner

51

Metformin XR – possible causes of intolerance

Zbynek Schroner

52

20 years of the Diabetology Education Center in Martin

Andrea Bukovská

55

7th National SDS Symposium: Where are we moving with technology in diabetes in Slovakia

Viera Doničová

59

Interdisciplinary Dialogue on the Treatment of Cardio-metabolic Syndrome (31 January – 1 February 2025, Bratislava): report

Zbynek Schroner

64

Advanced Technologies & Treatments for Diabetes, Amsterdam, 19–22 March 2025

Adriana Ilavská

66

MUDr. Michaela Važanová – portrét ambulantnej diabetologičky

67

MUDr. Viliam Vaník – portrét ambulantného diabetóga

Diabetes and obesity - Issue 1/2025

Editorial

Reviews

Case studies

News

News

Personalities

Diabetes and obesity